Short ribosomal prophylaxis in the prevention of clinical recurrences of chronic otitis media in children

International Journal of Pediatric Otorhinolaryngology

Volumn 68, Issue 1, 2004, Pages 83-89

  Renzo, Mora ^a   Giovanni, Ralli ^a   Maria, Passali Francesco ^a   Barbara, Crippa ^a   Stefano, Ottoboni ^a   Francesco, Mora ^a   Marco, Barbieri ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Children; Otitis media; Ribosomal therapy

Indexed keywords

IMMUNOGLOBULIN; RIBOMUNYL;

ADOLESCENT; ARTICLE; CHILD; CHRONIC OTITIS MEDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEARING TEST; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARENT; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RIBOSOME; SELF EVALUATION; SYMPTOM; TREATMENT OUTCOME;

EID: 0347625937     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2003.09.008     Document Type: Article

References (21)

1. Rosenfeld J.A., Clarity G. Acute otitis media in children. Prim. Care. 23:1996;67786.
2. Cripps A.W., Kyd J. Bacterial otitis media: current vaccine development strategies. Immunol. Cell Biol. 81:2003;46-51.
3. Mora R., Barbieri M., Passali G.C., Sovatzis A., Mora F., Cordone M.P. A preventive measure for otitis media in children with upper respiratory tract infection. Int. J. Pediatr. Otorhinolaryngol. 63:2002;111-118.
4. Heikkinen T., Chonmaitree T. Increasing importance of viruses in acute otitis media. Ann. Med. 32:2000;157-163.
5. Heikkinen T., Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin. Microbiol. Rev. 16:2003;230-241.
6. Heikkinen T. The role of respiratory viruses in otitis media. Vaccine. 19:2002;51-55.
7. Marchese A., Ardito F., Fadda G., Fontana R., Lo Cascio G., Marcheti F., Nicoletti G., Speciale A.M., Schito A.M. Sentinel Project 2000: an update on the prevalence of antimicrobial resistance in common bacterial pathogens of respiratory tract infections circulating in Italy. GIMMOC. 6:2002;168-185.
8. Fiocchi A., Arancio R., Cinquepalmi P., Sala M., Zuccotti G.V., Riva E., Giovannini M. Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytal). J. Int. Med. Res. 18:1990;50-60.
9. de Martino M., Galli L., Vierucci A. May children with recurrent respiratory infections be a test bed of immunomodulators. Pharmacol. Res. 26:1992;156-159.
10. Dietrich G., Griot-Wenk M., Metcalfe I.C., Lang A.B., Viret J.F. Experience with registered mucosal vaccines. Vaccine. 21:2003;678-683.
11. Bene M.C., Faure G.C. From Peyer's patches to tonsils. Specific stimulation with ribosomal immunotherapy. Drugs. 54:1997;24-28.
12. Eriksson K., Holmgren J. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 14:2002;666-672.
13. Clot J. Pharmacology of ribosomal immunotherapy. Drugs. 54:1997;33-36.
14. Allavena P., Annalaura E., Pirelli A., Licciardello L., Mantovani A. Stimulation of cytotoxic and non-cytotoxic functions of natural killer cells by bacterial membrane proteoglycans and ribosomes. Int. J. Immunopharmacol. 11:1989;29-34.
15. Roques C., Frayret M.N., Luc J., Michel G., Rouquet R.M., Leophonte P., Dutau G. Immunostimulant effects on granulocyte functions during an acute respiratory infection. Dev. Biol. Stand. 77:1992;183-187.
16. Kolopp-Sarda M.N., Bene M.E., Allaire J.M., Perruchet A.M., Faure G.C. Kinetics of specific salivary IgA responses in man after oral challenge by ribosomal immunostimulant. Int. J. Immunopharmacol. 19:1997;181-186.
17. Takahashi H., Honjo I., Fujita A. Endoscopic findings at the pharyngeal orifice of the eustachian tube in otitis media with effusion. Eur. Arch. Otorhinolaryngol. 253:1996;42-44.
18. Moodly S.A., Alper C.M., Doyle W.J. Daily tympanometry in children during the cold season: association of otitis media with upper respiratory tract infections. Int. J. Pediatr. Otorhinolaryngol. 45:1998;143-150.
19. Rutishauser M., Pitzke P., Grevers G., van Aubel A., Elsasser U., Kammereit A. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study. Adv. Ther. 15:1998;330-341.
20. Johnson C.E., Belman S. The role of antibacterial therapy of acute otitis media in promoting drug resistance. Paediatr. Drugs. 3:2001;639-647.
21. Block S.L. Management of acute otitis media in the 1990s: the decade of resistant pneumococcus. Paediatr. Drugs. 1:1999;31-50.